GLP-1 Weight Loss Drugs Make People Move Less
New research shows people on Ozempic and similar drugs walk 560 fewer steps daily despite losing weight. People taking GLP-1 drugs like Ozempic dropped from…
New research shows people on Ozempic and similar drugs walk 560 fewer steps daily despite losing weight. People taking GLP-1 drugs like Ozempic dropped from…
FDA approval means children with diabetes can skip mealtime injections and manage blood sugar with a simple inhaler instead. The FDA just approved Afrezza inhaled…
The largest study ever done found prescription opioids barely outperform placebos for most pain conditions. University of Sydney researchers analyzed 59 systematic reviews covering over…
Losing 10-15% of body weight reduces sleep apnea symptoms by up to 50% in people with obesity. If you have sleep apnea and carry extra…
AstraZeneca's oral version worked as well as injections in trials, potentially opening these powerful drugs to needle-phobic patients. A new pill version of GLP-1 medication…
Three major studies found finerenone protects kidneys and hearts in millions with non-diabetic kidney disease too. A kidney medication called finerenone, previously approved only for…
New research identifies genetic variants that make GLP-1 drugs like Ozempic significantly less effective for diabetes control. About 1 in 10 people carry genetic variants…
New research shows Ozempic-type medications reduce blood pressure through multiple pathways, not just the scale. A meta-analysis of 43,618 adults found that GLP-1 medications like…
Eli Lilly's experimental drug helped people lose an average of 85 pounds in two years—matching surgical results. An experimental drug called retatrutide just delivered the…